PDCD1 and cancer: T cells are tightly regulated by immune checkpoint receptors, including programmed cell death protein 1 (PD-1), and checkpoint inhibitors in the form of specific blocking antibodies against PD-1, and its ligands have shown remarkable clinical efficacy in cancer treatment (13, 14).